Ilios has built a chemistry platform to generate multi-functional,
brain-penetrant small molecules rationally-designed to combat
neurodegenerative diseases. Our first-in-class therapeutics are designed
to synergistically address the three key mechanisms driving
neurodegenerative diseases: oxidative stress, brain inflammation, and
protein misfolding. Our first program is on Amyotrophic Lateral
Sclerosis (ALS), with plans to expand our therapeutic pipeline to
include treatments for Parkinson's and Alzheimer's diseases.
Ilios Therapeutics
Harvard Innovation Labs
Ilios Therapeutics
Combating neurodegenerative diseases through rationally-designed multi-functional small molecules.
